We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600688:SSESinopec Shanghai Petrochemical Co. Ltd. Class A Analysis

Data as of 2026-06-14 - not real-time

CN¥2.91

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 2.91, comfortably above the 20‑day (2.95) and 50‑day (2.93) simple moving averages, signaling a short‑term bullish bias. Volume is increasing and the technical trend is labeled bullish, while the RSI sits at 46.9, indicating neutral momentum. The MACD histogram is slightly negative and the signal line is bearish, suggesting a potential near‑term pullback toward the support level of CNY 2.70, with resistance near CNY 3.72. Volatility is elevated at ~61% over the past 30 days and beta is mildly negative (‑0.19), implying limited market‑wide correlation but high price swings.
Fundamentally, the company posted a 9.5% revenue decline and a negative profit margin of –1.26%, with trailing EPS of –0.09 and forward EPS of 0.06. The forward P/E of 48.5 is more than double the industry average of 21.5, while ROE and ROA are both negative, and operating as well as free cash flow are deeply in the red. Despite a modest dividend yield of 0.69%, the payout ratio is effectively zero, reflecting an unsustainable dividend given the loss‑making profile. The balance sheet shows a low debt‑to‑equity of 12.7% and net cash of CNY 3.9 bn, but cash generation is weak.
Market sentiment is extremely bullish, as indicated by a Fear‑Greed Index of 89.86 (“Extreme Greed”), yet the high valuation and deteriorating earnings create a disconnect. The combination of strong technical momentum, high volatility, and weak fundamentals leads to a cautious outlook, with short‑term price moves possible but limited upside potential unless earnings improve.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above short‑term moving averages
  • Increasing volume and bullish trend label
  • Negative MACD signal and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward EPS modestly positive but still high forward P/E
  • Persistent negative cash flow and margins
  • Support level providing downside cushion

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Overvalued relative to earnings and industry peers
  • Unsustainable dividend and ongoing losses
  • Elevated volatility and weak profitability outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-9.50%
Profit Margin-1.26%
P/E Ratio48.5
ROE-3.72%
ROA-1.12%
Debt/Equity12.73
P/B Ratio1.3
Op. Cash FlowCN¥-588011008
Free Cash FlowCN¥-2937416192
Industry P/E21.5

Technical Analysis

TrendBullish
RSI46.9
SupportCN¥2.70
ResistanceCN¥3.72
MA 20CN¥2.95
MA 50CN¥2.93
MA 200CN¥2.91
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue
Dividend Yield0.69%

Risk Assessment

Beta-0.19
Volatility60.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.